目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T6963 | Adrenergic Receptor Norepinephrine | ||
Reboxetine mesylate (FCE20124 mesylate) 是一种高效、选择性的,特异性的去甲肾上腺素再摄取抑制剂(NARI),能够抑制去甲肾上腺素再摄取(Ki=8 nM),可用于抑郁症的研究。 | |||
T2092 | Dopamine Receptor 5-HT Receptor Serotonin Transporter Norepinephrine | ||
Amitifadine hydrochloride (EB-1010 hydrochloride) 是一种 5-羟色胺-去甲肾上腺素-多巴胺的再摄取抑制剂(SNDRI),其在 HEK 293 细胞中测得的 IC50值分别为 12, 23, 96 nM。 | |||
T5380 | Dopamine Receptor 5-HT Receptor Norepinephrine | ||
Ansofaxine hydrochloride (LY03005) 是一种血清素-去甲肾上腺素-多巴胺再摄取抑制剂,IC50值分别为723、491 和 763 nM。 | |||
T9395 | Others | ||
(1S,4R)-N-DesmethylSertralineHydrochloride 是一种Serotonin transporter 和 Norepinephrine transporter 抑制剂,IC5分别为19 nM 和35 nM. | |||
T3526 | Dopamine Receptor 5-HT Receptor Serotonin Transporter Norepinephrine | ||
Dasotraline hydrochloride (SEP-225289 hydrochloride) 是具有阻断多巴胺 (IC50=4 nM),去甲肾上腺素 (IC50=6 nM) 和三羟色胺转运蛋白 (IC50=11 nM)的三重再摄取抑制剂。 | |||
T23711 | |||
WAY-260022 is the norepinephrine transporter inhibitor. | |||
T0869 | Dopamine Receptor 5-HT Receptor Norepinephrine | ||
Atomoxetine hydrochloride (LY 139603) 是苯氧基-3-丙胺衍生物和选择性非兴奋剂,是去甲肾上腺素再摄取抑制剂,具有认知增强活性。 与人 NET,SERT 和 DAT 的放射性配体结合的 Ki 分别为5,77和1451 nM。 | |||
T6188 | 5-HT Receptor Serotonin Transporter Norepinephrine | ||
Desvenlafaxine succinate hydrate (WY 45233 Succinate) 是 Venlafaxine 主要代谢物的丁二酸盐形式,在人多巴胺转运体上显示弱的结合亲和力。它是具有口服活性的、能透过血脑屏障的5-HT 和 去甲肾上腺素再摄取的抑制剂,对 hSERT 和 hNET 的IC50值分别为47.3 nM 和531.3 nM。 | |||
T11087 | Dopamine Receptor Serotonin Transporter Norepinephrine | ||
DOV-216,303 Free Base (DOV-216303) 是血清素、去甲肾上腺素和多巴胺再摄取的抑制剂,IC50 为 14、20 和 78 nM。 DOV-216,303 Free Base 具有抗抑郁作用。 | |||
T0871 | Adrenergic Receptor | ||
Noradrenaline bitartrate 直接作用于 α 和 β 肾上腺素能受体。它是去甲肾上腺素的酒石酸氢盐,去甲肾上腺素是一种合成苯乙胺,可模拟内源性去甲肾上腺素的拟交感神经作用。临床上,去甲肾上腺素用作外周血管收缩剂,通过其α-肾上腺素能作用导致动脉和静脉床收缩。它还被用作通过其 β-1 肾上腺素能作用介导的强效正性肌力和变时性心脏刺激剂。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-03852 | Dopamine beta-Hydroxylase Protein, Human, Recombinant (His) | Human | HEK293 | ||
DBH is a 29 kDa copper-containing oxygenase. It can be detected in noradrenergic nerve terminals of the central and peripheral nervous systems, and is also expressed in chromaffin cells of the adrenal medulla. DBH contains our identical subunits, and its activity requires ascorbate as a cofactor. It functions in in the synthesis of small-molecule neurotransmitters that is membrane-bound, making norepinephrine the only transmitter synthesized inside vesicles. DBH has been shown to be associated with decision making and addictive behaviors such as alcohol and smoking, attention deficit hyperactivity disorder, and also with neurological diseases such as Schizophrenia and Alzheimer's.
|
|||||
TMPY-02948 | SULT1A3 Protein, Human, Recombinant (His) | Human | E. coli | ||
SULT1A3 belongs to the sulfotransferase 1 family. Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. They are different in their tissue distributions and substrate specificities while their gene structure (number and length of exons) is similar. SULT1A3 gene encodes a phenol sulfotransferase with thermolabile enzyme activity. Four sulfotransferase genes are located on the p arm of chromosome 16; this gene and SULT1A4 arose from a segmental duplication. It is the most centromeric of the four sulfotransferase genes. Exons of this gene overlap with exons of a gene that encodes a protein containing GIY-YIG domains (GIYD1). SULT1A3 is expressed in liver, colon, kidney, lung, brain, spleen, small intestine, placenta and leukocyte. SULT1A3 is a sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic monoamines (neurotransmitters such as dopamine, norepinephrine and serotonin) and phenolic and catechol drugs.
|